165 related articles for article (PubMed ID: 21805106)
21. The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.
Youssof S
Muscle Nerve; 2016 May; 53(5):694-9. PubMed ID: 26453481
[TBL] [Abstract][Full Text] [Related]
22. Patient-reported disease burden in oculopharyngeal muscular dystrophy.
Kurtz NS; Cote C; Heatwole C; Gagnon C; Youssof S
Muscle Nerve; 2019 Dec; 60(6):724-731. PubMed ID: 31531865
[TBL] [Abstract][Full Text] [Related]
23. Cricopharyngeal myotomy in the treatment of oculopharyngeal muscular dystrophy.
Gómez-Torres A; Abrante Jiménez A; Rivas Infante E; Menoyo Bueno A; Tirado Zamora I; Esteban Ortega F
Acta Otorrinolaringol Esp; 2012; 63(6):465-9. PubMed ID: 22898142
[TBL] [Abstract][Full Text] [Related]
24. Introducing the Dysphagiameter: a novel patient-reported outcome measure for evaluating dysphagia in oculopharyngeal muscular dystrophy - from conceptual framework to initial development.
Côté C; Brais B; Sèbiyo Batcho C; Brisson JD; Youssof S; Allegue DR; Gagnon C
Neuromuscul Disord; 2023 Nov; 33(11):856-865. PubMed ID: 37923656
[TBL] [Abstract][Full Text] [Related]
25. Oculopharyngeal Muscular Dystrophy, an Often Misdiagnosed Neuromuscular Disorder: A Southern California Experience.
Goyal NA; Mozaffar T; Chui LA
J Clin Neuromuscul Dis; 2019 Dec; 21(2):61-68. PubMed ID: 31743248
[TBL] [Abstract][Full Text] [Related]
26. Swallow characteristics in patients with oculopharyngeal muscular dystrophy.
Palmer PM; Neel AT; Sprouls G; Morrison L
J Speech Lang Hear Res; 2010 Dec; 53(6):1567-78. PubMed ID: 20699340
[TBL] [Abstract][Full Text] [Related]
27. Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?
Rüegg S; Lehky Hagen M; Hohl U; Kappos L; Fuhr P; Plasilov M; Müller H; Heinimann K
Swiss Med Wkly; 2005 Oct; 135(39-40):574-86. PubMed ID: 16333769
[TBL] [Abstract][Full Text] [Related]
28. Oculopharyngeal muscular dystrophy (OPMD) and dementia in a 75-year-old female.
Nisbet MK; Marshall L
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537606
[TBL] [Abstract][Full Text] [Related]
29. Dilatation therapy for dysphagia in patients with upper esophageal sphincter dysfunction--manometric and symptomatic response.
Hatlebakk JG; Castell JA; Spiegel J; Paoletti V; Katz PO; Castell DO
Dis Esophagus; 1998 Oct; 11(4):254-9. PubMed ID: 10071809
[TBL] [Abstract][Full Text] [Related]
30. Oculopharyngeal muscular dystrophy as a rare cause of dysphagia.
Werling S; Schrank B; Eckardt AJ; Hauburger A; Deschauer M; Müller M
Ann Gastroenterol; 2015; 28(2):291-293. PubMed ID: 25831437
[TBL] [Abstract][Full Text] [Related]
31. Ptosis aggravates dysphagia in oculopharyngeal muscular dystrophy.
de Swart BJ; van der Sluijs BM; Vos AM; Kalf JG; Knuijt S; Cruysberg JR; van Engelen BG
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):266-8. PubMed ID: 16421137
[TBL] [Abstract][Full Text] [Related]
32. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease.
Hill M; Hughes T; Milford C
Cochrane Database Syst Rev; 2004; (2):CD004303. PubMed ID: 15106246
[TBL] [Abstract][Full Text] [Related]
33. Office-Based Cricopharyngeus Balloon Dilation for Post Chemoirradiation Dysphagia in Nasopharyngeal Carcinoma Patients: A Pilot Study.
Fong R; Sun N; Ng YW; Rumbach AF; Ward EC; Tsang R
Dysphagia; 2019 Aug; 34(4):540-547. PubMed ID: 30888528
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of large-diameter dilatation in cricopharyngeal dysfunction.
Clary MS; Daniero JJ; Keith SW; Boon MS; Spiegel JR
Laryngoscope; 2011 Dec; 121(12):2521-5. PubMed ID: 21997884
[TBL] [Abstract][Full Text] [Related]
35. Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD).
Melkus G; Sampaio ML; Smith IC; Rakhra KS; Bourque PR; Breiner A; Zwicker J; Lochmüller H; Brais B; Warman-Chardon J
Neuromuscul Disord; 2023 Jan; 33(1):24-31. PubMed ID: 36462961
[TBL] [Abstract][Full Text] [Related]
36. Dysphagia in oculopharyngeal muscular dystrophy: a series of 22 French cases.
Périé S; Eymard B; Laccourreye L; Chaussade S; Fardeau M; Lacau St Guily J
Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S96-9. PubMed ID: 9392025
[TBL] [Abstract][Full Text] [Related]
37. Cricopharyngeal myotomy in the management of neurogenic and muscular dysphagia.
Duranceau A
Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S85-9. PubMed ID: 9392023
[TBL] [Abstract][Full Text] [Related]
38. Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.
Malerba A; Klein P; Lu-Nguyen N; Cappellari O; Strings-Ufombah V; Harbaran S; Roelvink P; Suhy D; Trollet C; Dickson G
Hum Mol Genet; 2019 Oct; 28(19):3301-3308. PubMed ID: 31294444
[TBL] [Abstract][Full Text] [Related]
39. Oculopharyngeal muscular dystrophy associated with dementia.
Mizoi Y; Yamamoto T; Minami N; Ohkuma A; Nonaka I; Nishino I; Tamura N; Amano T; Araki N
Intern Med; 2011; 50(20):2409-12. PubMed ID: 22001477
[TBL] [Abstract][Full Text] [Related]
40. Savary dilation is a safe and effective long-term means of treatment of symptomatic cricopharyngeal bar: a single-center experience.
Patel BJ; Mathur AK; Dehom S; Jackson CS
J Clin Gastroenterol; 2014 Jul; 48(6):500-4. PubMed ID: 24231933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
